Hemofarm Plans New Investments of EUR 100 Million

Hemofarm is planning new investments in the amount of almost EUR 100 million, and this year they expect double-digit growth, said Ronald Seeliger, CEO of Hemofarm, as announced by the company in a press release.

Speaking about the planned investments, Seeliger pointed out that numerous projects are being prepared in the next few years, which will put Hemofarm “in the ranks of mega-production sites, even in the international framework.”

– The amount of investment we are planning is close to EUR 100 million and it will be invested in an area that will ensure a constant supply. This investment is part of our commitment and determination to secure the supply chain going forward – Seeliger said and emphasized that in 2023 he expects double-digit growth.

Hemofarm a.d. Vršac

Hemofarm

Ronald Seeliger

investments of Hemofarm